Nu-Med Plus (NUMD) EPS (Basic) Growth (3y) (2015 - 2025)
Nu-Med Plus (NUMD) EPS (Basic) Growth (3y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.34 Bn | 7.27 Bn | -12.28% |
| 2 | Stryker | 127.40 Bn | 123.93 Bn | 4.50 Bn | 19.63% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 3.18% |
| 4 | Boston Scientific | 73.24 Bn | 72.71 Bn | 3.85 Bn | 50.64% |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.70 Bn | 1.35 Bn | -6.23% |
| 6 | Dexcom | 34.39 Bn | 32.44 Bn | 830.00 Mn | 29.56% |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn | 11.31% |
| 8 | Koninklijke Philips | 26.34 Bn | 23.02 Bn | 4.55 Bn | 1,801.39% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 17.98% |
| 10 | Nu-Med Plus | 2.03 Mn | 2.02 Mn | - | 40.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -31.68% |
| Sep 30, 2025 | 41.84% |
| Jun 30, 2025 | 42.43% |
| Mar 31, 2025 | 31.79% |
| Dec 31, 2024 | 83.81% |
| Sep 30, 2024 | 46.41% |
| Jun 30, 2024 | 58.88% |
| Mar 31, 2024 | 61.28% |
| Dec 31, 2023 | 57.94% |
| Sep 30, 2023 | 71.84% |
| Jun 30, 2023 | 75.03% |
| Mar 31, 2023 | 52.78% |
| Dec 31, 2022 | 28.34% |
| Sep 30, 2022 | 39.43% |
| Jun 30, 2022 | 48.87% |
| Mar 31, 2022 | 58.24% |
| Dec 31, 2021 | -52.10% |
| Sep 30, 2021 | 51.71% |
| Jun 30, 2021 | 10.98% |
| Mar 31, 2021 | -7.11% |